Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
Li Qun Zhou, K.W. Yang, S. Zhang, Xieqiao Yan, S.M. Li, Huayan Xu and 10 more
- Rank
- 38 of 3,853
- Percentile
- top 1%
- Where
- Annals of Oncology, 2024
- Citations
- 69
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.